UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical Studies

The AAPS journal, 2018-03, Vol.20 (2), p.28-28, Article 28

2018

Volltextzugriff (PDF)

Thymic Lymphomas in a 6-Month rasH2-Tg Mouse Carcinogenicity Study With the RORγt Inverse Agonist, BMS-986251

Toxicological sciences, 2021-09, Vol.183 (1), p.93-104

2021

Volltextzugriff (PDF)

Decreased immune response in monkeys administered a human T-effector cell agonist (OX40) antibody

Toxicology and applied pharmacology, 2020-12, Vol.409, p.115285, Article 115285

2020

Volltextzugriff (PDF)

Characterizing the Randot Preschool stereotest: Testability, norms, reliability, specificity and sensitivity in children aged 2-11 years

PloS one, 2019-11, Vol.14 (11), p.e0224402-e0224402

2019

Volltextzugriff (PDF)

Bioavailability of protein therapeutics in rats following inhalation exposure: Relevance to occupational exposure limit calculations

Regulatory toxicology and pharmacology, 2018-12, Vol.100, p.35-44

2018

Volltextzugriff (PDF)

Chronic administration of belatacept, a T-cell costimulatory signal blocker, in cynomolgus monkeys

Toxicological sciences, 2012-05, Vol.127 (1), p.159-168

2012

Volltextzugriff (PDF)

Evaluation of immunogenicity of the T cell costimulation modulator abatacept in patients treated for rheumatoid arthritis

Journal of rheumatology, 2007-12, Vol.34 (12), p.2365

2007

Volltextzugriff (PDF)

Immunomodulation and lymphoma in humans

Journal of immunotoxicology, 2014-01, Vol.11 (1), p.1-12

2014

Volltextzugriff (PDF)

Immunotoxicity Testing in Non-Rodent Species

Journal of immunotoxicology, 2007-04, Vol.4 (2), p.165-169

Haggerty, Helen G.

2007

Volltextzugriff (PDF)

Methods: Implementation of in vitro and ex vivo phagocytosis and respiratory burst function assessments in safety testing

Journal of immunotoxicology, 2013-01, Vol.10 (1), p.106-117

2013

Volltextzugriff (PDF)

Task force report: Future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions

Journal of allergy and clinical immunology, 2002-03, Vol.109 (3), p.461-478

2002

Volltextzugriff (PDF)

Abstract LB-B33: Nonclinical safety evaluation of two distinct second generation variants of anti-CTLA4 monoclonal antibody, ipilimumab, in monkeys

Molecular cancer therapeutics, 2018-01, Vol.17 (1_Supplement), p.LB-B33-LB-B33

2018

Volltextzugriff (PDF)

ASTEROID: A New Clinical Stereotest on an Autostereo 3D Tablet

Translational vision science & technology, 2019-01, Vol.8 (1), p.25-25

2019

Volltextzugriff (PDF)

Meeting Report Immune-Mediated Drug Hypersensitivity Reactions (IDHR) Workshop

Journal of immunotoxicology, 2005, Vol.1 (3-4), p.201-205

2005

Volltextzugriff (PDF)

The use of the Newcastle Control Score in the management of intermittent exotropia

British journal of ophthalmology, 2007-02, Vol.91 (2), p.215-218

2007

Volltextzugriff (PDF)

Summary of roundtable discussion meeting: Non-human primates to assess risk for EBV-related lymphomas in humans

Journal of immunotoxicology, 2012-01, Vol.9 (1), p.121-127

2012

Volltextzugriff (PDF)

Abatacept treatment does not exacerbate chronic Mycobacterium tuberculosis infection in mice

Arthritis and rheumatism, 2007-08, Vol.56 (8), p.2557-2565

2007

Volltextzugriff (PDF)

Role of metabolism in dimethylnitrosamine-induced immunosuppression: a review

Toxicology (Amsterdam), 1990-07, Vol.63 (1), p.1-23

1990

Volltextzugriff (PDF)

Nonclinical Safety Strategy for Combinations of Biopharmaceuticals or a Biopharmaceutical with a Small Molecular Weight Compound

Translational Medicine, 2022, p.163-174

1, 2022

Volltextzugriff (PDF)

Improvements in BSV following squint surgery in Grave’s ophthalmology

Journal of AAPOS, 2007, Vol.11 (1), p.83-83

2007

Volltextzugriff (PDF)

Prevention of immunotoxin-induced immunogenicity by coadministration with CTLA4Ig enhances antitumor efficacy

The Journal of immunology (1950), 1997-11, Vol.159 (10), p.5168-5173

1997

Volltextzugriff (PDF)

A modified method for measuring uniocular fields of fixation: reliability in healthy subjects and in patients with Graves orbitopathy

Archives of ophthalmology (1960), 2005-03, Vol.123 (3), p.356

2005

Volltextzugriff (PDF)

BR96 sFv-PE40 Immunotoxin: Nonclinical Safety Assessment

Toxicologic pathology, 1999-01, Vol.27 (1), p.87-94

1999

Volltextzugriff (PDF)

ABATACEPT TREATMENT DOES NOT IMPAIR HOST RESISTANCE TO CHRONIC MYCOBACTERIUM TUBERCULOSIS INFECTION IN MICE: 148

Journal of clinical rheumatology, 2006-08, Vol.12 (Supplement), p.S47-S48

2006

Volltextzugriff (PDF)

A Mutant of the WEHI-231 B Lymphocyte Line That Is Resistant to Phorbol Esters Is Still Sensitive to Antigen Receptor-Mediated Growth Inhibition

Cellular immunology, 1994-03, Vol.154 (1), p.166-180

1994

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(46)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical Studies

Thymic Lymphomas in a 6-Month rasH2-Tg Mouse Carcinogenicity Study With the RORγt Inverse Agonist, BMS-986251

Decreased immune response in monkeys administered a human T-effector cell agonist (OX40) antibody

Characterizing the Randot Preschool stereotest: Testability, norms, reliability, specificity and sensitivity in children aged 2-11 years

Bioavailability of protein therapeutics in rats following inhalation exposure: Relevance to occupational exposure limit calculations

Chronic administration of belatacept, a T-cell costimulatory signal blocker, in cynomolgus monkeys

Evaluation of immunogenicity of the T cell costimulation modulator abatacept in patients treated for rheumatoid arthritis

Immunomodulation and lymphoma in humans

Immunotoxicity Testing in Non-Rodent Species

Methods: Implementation of in vitro and ex vivo phagocytosis and respiratory burst function assessments in safety testing

Task force report: Future research needs for the prevention and management of immune-mediated drug hypersensitivity reactions

Abstract LB-B33: Nonclinical safety evaluation of two distinct second generation variants of anti-CTLA4 monoclonal antibody, ipilimumab, in monkeys

ASTEROID: A New Clinical Stereotest on an Autostereo 3D Tablet

Meeting Report Immune-Mediated Drug Hypersensitivity Reactions (IDHR) Workshop

The use of the Newcastle Control Score in the management of intermittent exotropia

Summary of roundtable discussion meeting: Non-human primates to assess risk for EBV-related lymphomas in humans

Abatacept treatment does not exacerbate chronic Mycobacterium tuberculosis infection in mice

Role of metabolism in dimethylnitrosamine-induced immunosuppression: a review

Nonclinical Safety Strategy for Combinations of Biopharmaceuticals or a Biopharmaceutical with a Small Molecular Weight Compound

Improvements in BSV following squint surgery in Grave’s ophthalmology

Prevention of immunotoxin-induced immunogenicity by coadministration with CTLA4Ig enhances antitumor efficacy

A modified method for measuring uniocular fields of fixation: reliability in healthy subjects and in patients with Graves orbitopathy

BR96 sFv-PE40 Immunotoxin: Nonclinical Safety Assessment

ABATACEPT TREATMENT DOES NOT IMPAIR HOST RESISTANCE TO CHRONIC MYCOBACTERIUM TUBERCULOSIS INFECTION IN MICE: 148

A Mutant of the WEHI-231 B Lymphocyte Line That Is Resistant to Phorbol Esters Is Still Sensitive to Antigen Receptor-Mediated Growth Inhibition

Suchergebnisse filtern